None
Quote | Poxel SA (OTCMKTS:PXXLF)
Last: | $0.70 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.70 |
High: | $0 |
Low: | $0 |
Volume: | 1,000 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Poxel SA (OTCMKTS:PXXLF)
Patent Term Extension (PTE) approved in Japan for 2 patents related to TWYMEEG ® , extending the product patent life until 2036 Exclusive discussions being finalized with a leading investor to monetize royalties from sales of TWYMEEG ® (Imeglimin) in Japan As of ...
TWYMEEG ® gross sales in Japan for Sumitomo Pharma Fiscal Year 2023 1 reached JPY 4.6 billion (EUR 27.9 million) 2 , exceeding guidance 3 by more than 8% TWYMEEG ® ’s FY 2024 forecast 4 of JPY 11.3 billion (EUR 69.1 million 2 ) would represent ...
Message Board Posts | Poxel SA (OTCMKTS:PXXLF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Poxel SA Company Name:
PXXLF Stock Symbol:
OTCMKTS Market:
Patent Term Extension (PTE) approved in Japan for 2 patents related to TWYMEEG ® , extending the product patent life until 2036 Exclusive discussions being finalized with a leading investor to monetize royalties from sales of TWYMEEG ® (Imeglimin) in Japan As of ...
TWYMEEG ® gross sales in Japan for Sumitomo Pharma Fiscal Year 2023 1 reached JPY 4.6 billion (EUR 27.9 million) 2 , exceeding guidance 3 by more than 8% TWYMEEG ® ’s FY 2024 forecast 4 of JPY 11.3 billion (EUR 69.1 million 2 ) would represent ...
TWYMEEG gross sales in Japan should exceed its FY 2023 1 guidance 2 of JPY 4.2 billion (EUR 25.7 million) 3 driven by a favourable sales trend in Japan. Sumitomo Pharma to report full year results on May 14 th , 2024 Company expects TWYMEEG’s FY 2024 4 forecast ...